1. Berbari EF, Kanj SS, Kowalski TJ, Darouiche RO, Widmer AF, Schmitt SK, Hendershot EF, Holtom PD, Huddleston PM 3rd, Petermann GW, Osmon DR, Infectious Diseases Society of Ame-
rica. 2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adults. Clin Infect Dis. 2015 Sep
15;61(6):e26-46. doi: 10.1093/cid/civ482. Epub 2015 Jul 29. PMID: 26229122.
2. ConanY,LaurentE,BelinY,LacasseM,AmelotA,Mulleman D, Rosset P, Bernard L, Grammatico-Guillon L (2021) Large Increase of Vertebral Osteomyelitis in France: A 2010–2019 Cross-Sec-
tional Study. Epidemiol Infect 149:e227. https://doi. org/10.1017/S0950268821002181
3. LandiA,GrassoG,IaianiG,GregoriF,MancarellaC,diBar- tolomeo A, Domenicucci M, Delfini R (2017) Spontaneous Spi- nal Discitis and Spondylodiscitis: Clinicotherapeutic Remarks. J
Neurosci Rural Pract 8:642–646. https://doi.org/10.4103/jnrp. jnrp_67_17
4. Abram SR, Tedeschi AA, Partain CL, Blumenkopf B. Differential diag- nosis of severe back pain using MRI. South Med J 1988; 81:1487–92.
5. Gupta A, Kowalski TJ, Osmon DR, et al. Long-term outcome of pyo- genic vertebral osteomyelitis: a cohort study of 260 patients. Open Forum Infect Dis 2014; 1:8.
6. Zou X, Li X, He K, Song Q, Yin R. Current knowledge of vertebral osteomyelitis: a review. Eur J Clin Microbiol Infect Dis. 2025 Feb;44(2):213-231. doi: 10.1007/s10096-024-04983-9. Epub
2024 Nov 26. PMID: 39589654.
7. Kayani I, Syed I, Saifuddin A, Green R, MacSweeney F. Vertebral osteomyelitis without disc involvement. Clin Radiol. 2004 Oct;59(10):881-91. doi: 10.1016/j.crad.2004.03.023. Erratum in:
Clin Radiol. 2004 Dec;59(12):1146. Kamani, I [corrected to Kayani, I]. PMID: 15451346.
8. Doutchi M, Seng P, Menard A, et al. Changing trends in the epidemiology of vertebral osteomyelitis in Marseille, France. New Microbes New Infect 2015; 7:1.
9. Piccolo CL, Villanacci A, Di Stefano F, Fusco N, Donno DR, Cristofaro M, Taglietti F, Ianniello S. Spondylodiscitis and Its Mimickers: A Pictorial Review. Biomedicines. 2024 Nov 9;12(11):2566.
doi: 10.3390/biomedicines12112566. PMID: 39595132; PMCID: PMC11591932.
10. LangS,WalterN,SchindlerM,BaertlS,SzymskiD,LoiblM, Alt V, Rupp M (2023) The Epidemiology of Spondylodiscitis in Germany: A Descriptive Report of Incidence Rates, Pathogens, In-Hos-
pital Mortality, and Hospital Stays between 2010 and 2020. J Clin Med 12:3373. https://doi.org/10.3390/jcm12103373
11. Bernard L, Dinh A, Ghout I, et al. Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled
trial. Lancet 2015; 385:875.
12. AkiyamaT,ChikudaH,YasunagaH,HoriguchiH,FushimiK, Saita K (2013) Incidence and Risk Factors for Mortality of Ver- tebral Osteomyelitis: A Retrospective Analysis Using the Japa- nese
Diagnosis Procedure Combination Database. BMJ Open 3:e002412.https://doi.org/10.1136/bmjopen-2012-002412
13. HeckVJ,PrasseT,KlugK,Vinas-RiosJM,OikonomidisS,Klug A, Kernich N, Weber M, von der Höh N, Lenz M et al (2024) The Projected Increase of Vertebral Osteomyelitis in Germany Implies
a Demanding Challenge for Future Healthcare Manage- ment of Aging Populations. Infection. https://doi.org/10.1007/ s15010-024-02243-8 ..
14. Pigrau C, Rodríguez-Pardo D, Fernández-Hidalgo N, et al. Health care associated hematogenous pyogenic vertebral osteomyelitis: a severe and potentially preventable infectious disease.
Medicine (Baltimore) 2015; 94:e365.
15. TsantesAG,PapadopoulosDV,VrioniG,SioutisS,SapkasG, Benzakour A, Benzakour T, Angelini A, Ruggieri P, Mavrogenis AF et al (2020) Spinal Infections: An Update Microorganisms 8:476.
https://doi.org/10.3390/microorganisms8040476
16. Cottle L, Riordan T (2008) Infectious Spondylodiscitis. J Infect 56:401–412. https://doi.org/10.1016/j.jinf.2008.02.005
17. Mylona E, Samarkos M, Kakalou E, Fanourgiakis P, Skoutelis A. Pyogenic vertebral osteomyelitis: a systematic review of clinical characteristics. Semin Arthritis Rheum. 2009 Aug;39(1):10-7.
doi: 10.1016/j.semarthrit.2008.03.002. Epub 2008 Jun 11. PMID: 18550153.
18. Batson OV. THE FUNCTION OF THE VERTEBRAL VEINS AND THEIR ROLE IN THE SPREAD OF METASTASES. Ann Surg 1940; 112:138.
19. HENRIQUES CQ. Osteomyelitis as a complication in urology; with special reference to the paravertebral venous plexus. Br J Surg 1958; 46:19.
20. Larson DL, Hudak KA, Waring WP, et al. Protocol management of late-stage pressure ulcers: a 5-year retrospective study of 101 consecutive patients with 179 ulcers. Plast Reconstr Surg 2012;
129:897.
21. https://www.uptodate.com/contents/vertebral-osteomyelitis-in-adults-clinical-manifestations-and-diagnosis Topic 7663 Version 53.0
22. Kim WJ, Park C, Sarraf K. Management of vertebral osteomyelitis in adults. Br J Hosp Med (Lond). 2023 Jan 2;84(1):1-5. doi: 10.12968/hmed.2022.0362. Epub 2023 Jan 16. PMID: 36708343.
23. Park KH, Kim DY, Lee YM, et al. Selection of an appropriate empiric antibiotic regimen in hematogenous vertebral osteomyelitis. PLoS One 2019; 14:e0211888.
24. Greig JM, Wood MJ. Staphylococcus lugdunensis vertebral osteomyeli- tis. Clin Microbiol Infect 2003; 9:1139–41.
25. Sato K, Yamada K, Yokosuka K, Yoshida T, Goto M, Matsubara T, Iwahashi S, Shimazaki T, Nagata K, Shiba N et al (2019) Pyo- genic Spondylitis: Clinical Features. Diagnosis and Treatment
Kurume Med J 65:83–89. https://doi.org/10.2739/kurumemedj. MS653001
26. Euba G, Narváez JA, Nolla JM, Murillo O, Narváez J, Gómez- Vaquero C, Ariza J (2008) Long-Term Clinical and Radiological Magnetic Resonance Imaging Outcome of Abscess-Associated
Spontaneous Pyogenic Vertebral Osteomyelitis under Conserva- tive Management. Semin Arthritis Rheum 38:28–40. https://doi. org/10.1016/j.semarthrit.2007.08.007
27. Grados F, Lescure FX, Senneville E, Flipo RM, Schmit JL, Fardellone P (2007) Suggestions for Managing Pyogenic (Non- Tuberculous) Discitis in Adults. Joint Bone Spine 74:133–139.https://
doi.org/10.1016/j.jbspin.2006.11.002
28. Bhavan KP, Marschall J, Olsen MA, Fraser VJ, Wright NM, Warren DK. The epidemiology of hematogenous vertebral osteomyelitis: a cohort study in a tertiary care hospital. BMC Infect Dis.
2010 Jun 7;10:158. doi: 10.1186/1471-2334-10-158. PMID: 20529294; PMCID: PMC2894835.
29. Skoutelis A, Gogos C, Siampi V, Dimitracopoulos G, Bassaris H (2001) Salmonella Westerstede Vertebral Osteomyelitis and Sepsis in an Immunocompetent Patient. International journal of
infectious diseases: IJID: official publication of the Interna- tional Society for Infectious Diseases 5:228–229. https://doi. org/10.1016/s1201-9712(01)90078-5
30. Meher SK, Jain H, Tripathy LN, Basu S (2016) Chronic Pseu- domonas Aeruginosa Cervical Osteomyelitis. J Craniovertebr Junction Spine 7:276–278. https://doi.org/10.4103/0974-8237.
193264
31. McHenry MC, Easley KA, Locker GA (2002) Vertebral Osteo- myelitis: Long-Term Outcome for 253 Patients from 7 Cleve- land-Area Hospitals. Clinical Infectious Diseases: An Official
Publication of the Infectious Diseases Society of America 34:1342–1350. https://doi.org/10.1086/340102
32. Loibl M, Stoyanov L, Doenitz C, Brawanski A, Wiggermann P, Krutsch W, Nerlich M, Oszwald M, Neumann C, Salzberger B et al (2014) Outcome-Related Co-Factors in 105 Cases of Vertebral
Osteomyelitis in a Tertiary Care Hospital. Infection 42:503–510. https://doi.org/10.1007/s15010-013-0582-0
33. Elgouhari H, Othman M, Gerstein WH (2007) Bacteroides Fra- gilis Vertebral Osteomyelitis: Case Report and a Review of the Literature. South Med J 100:506–511. https://doi.org/10.1097/
01.smj.0000262587.48592.56
34. Froissart A, Pagnoux C, Cherin P. Lymph node paradoxical enlarge- ment during treatment for tuberculous spondylodiscitis (Pott’s dis- ease). Joint Bone Spine 2007; 74:292–5.
35. Gouliouris T, Aliyu SH, Brown NM. Spondylodiscitis: update on diag- nosis and management. J Antimicrob Chemother 2010; 65(suppl 3): iii11–24.
36. Mete B, Kurt C, Yilmaz MH, et al. Vertebral osteomyelitis: eight years’ experience of 100 cases. Rheumatol Int 2012; 32:3591–7.
37. Sakkas LI, Davas EM, Kapsalaki E, et al. Hematogenous spinal infec- tion in central Greece. Spine 2009; 34:E513–8.
38. Memish ZA, Balkhy HH. Brucellosis and international travel. J Travel Med 2004; 11:49–55.
39. Nolla JM, Ariza J, Gómez-Vaquero C, et al. Spontaneous pyogenic vertebral osteomyelitis in nondrug users. Semin Arthritis Rheum 2002; 31:271.
40. Gezercan Y, Ökten AI, Çavuş G, Açık V, Bilgin E (2017) Spinal Hydatid Cyst Disease World Neurosurg 108:407–417. https://doi. org/10.1016/j.wneu.2017.09.015.
41. Garcia-Gubern C, Fuentes CR, Colon-Rolon L, Masvidal D (2010) Spinal Cord Toxoplasmosis as an Unusual Presentation of AIDS: Case Report and Review of the Literature. Int J Emerg Med
3:439–442. https://doi.org/10.1007/s12245-010-0207-7
42. Geisler Crone C, Mose Tetens M, Bengaard Andersen A, et al. Clinical characteristics of pyogenic vertebral osteomyelitis, and factors associated with inadequate treatment response. Int J
Infect Dis 2021;108:487–93.
43. Pola E, Taccari F, Autore G, et al. Multidisciplinary management of pyogenic spondylodiscitis: epidemiological and clinical features, prognostic factors and long-term outcomes in 207 patients.
Eur Spine J 2018;27(Suppl 2):229–36.
44. Zimmerli W. Clinical practice. Vertebral osteomyelitis. N Engl J Med 2010; 362(11):1022–9.
45. Henry MW, Dowdell JE 3rd, Miller AO. Pyogenic Vertebral Osteomyelitis. Infect Dis Clin North Am. 2025 Sep;39(3):419-435. doi: 10.1016/j.idc.2025.02.011. Epub 2025 Apr 8. PMID:
40204566.
46. Tsantes AG, Papadopoulos DV, Vrioni G, et al. Spinal infections: an update. Mi- croorganisms 2020;8(4). https://doi.org/10.3390/microorganisms8040476.
47. Nabizadeh N, Crawford CH, Glassman SD, et al. Severity and outcome of neuro- logic deficits in patients with pyogenic spondylodiscitis: a systematic review. Or- thop Clin North Am
2022;53(1):105–12.
48. Vakili M, Crum-Cianflone NF. Spinal epidural abscess: a series of 101 cases. Am J Med 2017;130(12):1458–63.
49. Byamukama A, Acan M, Sebikali MJ (2023) Unusual Presenta- tion of Pott Disease and Diagnostic Challenges in a Resource- Limited Setting: A Case Report. J Med Case Rep 17:276. https://
doi.org/10.1186/s13256-023-04015-8
50. Shetty A, Kanna RM, Rajasekaran S (2016) TB Spine—Cur- rent Aspects on Clinical Presentation, Diagnosis, and Manage- ment Options. Seminars in Spine Surgery 28:150–162. https:// doi.
org/10.1053/j.semss.2015.07.006.
51. Garg RK, Somvanshi DS (2011) Spinal Tuberculosis: A Review. J Spinal Cord Med 34:440–454. https://doi.org/10. 1179/2045772311Y.0000000023
52. Khanna K, Sabharwal S (2019) Spinal Tuberculosis: A Com- prehensive Review for the Modern Spine Surgeon. Spine J 19:1858–1870. https://doi.org/10.1016/j.spinee.2019.05.002
53. Dunn, R.N.; Ben Husien, M. Spinal Tuberculosis: Review of Current Management. Bone Joint J 2018, 100-B, 425–431, https://doi.org/10.1302/0301-620X.100B4.BJJ-2017-1040.R1.
54. Rajasekaran S, Soundararajan DCR, Shetty AP, Kanna RM (2018) Spinal Tuberculosis: Current Concepts. Global Spine J 8:96S-108S. https://doi.org/10.1177/2192568218769053
55. Khoo LT, Mikawa K, Fessler RG. A surgical revisitation of Pott distemper of the spine. Spine J. 2003 Mar-Apr;3(2):130-45. doi: 10.1016/s1529-9430(02)00410-2. PMID: 14589227.
56. Fuentes Ferrer M, Gutiérrez Torres L, Ayala Ramírez O, et al. Tuberculosis of the spine. A systematic review of case series. Int Orthop 2012; 36:221.
57. Nussbaum ES, Rockswold GL, Bergman TA, et al. Spinal tuberculosis: a diagnostic and management challenge. J Neurosurg 1995; 83:243.
58. rau-Serrallach C, Rodríguez-Pardo D. Bone and joint tuberculosis. Eur Spine J 2013; 22 Suppl 4:556.
59. Esmaeilnejad-Ganji S.M., Esmaeilnejad-Ganji S.M.R. Osteoarticular manifestations of human brucellosis: A review. World J. Orthop. 2019;10:54–62. doi: 10.5312/wjo.v10.i2.54. [DOI] [PMC free
article] [PubMed] [Google Scholar] 60. Erdem H., Elaldi N., Batirel A., Aliyu S., Sengoz G., Pehlivanoglu F., Ramosaco E., Gulsun S., Tekin R., Mete B., et al. Comparison of brucellar and tuberculous spondylodiscitis patients: Results
of the multicenter “Backbone-1 Study”. Spine J. 2015;15:2509–2517. doi: 10.1016/j.spinee.2015.09.024. [DOI] [PubMed] [Google Scholar] 61. Waheed, G., Soliman, M. A. R., Ali, A. M., and Aly, M. H.: Spontaneous spondylodiscitis: review, incidence, management, and clinical outcome in 44 patients, Neurosurg. Focus, 46, E10,
https://doi.org/10.3171/2018.10.FOCUS18463, 2019.
62. Duarte RM, Vaccaro AR (2013) Spinal Infection: State of the Art and Management Algorithm. European Spine Journal: Official Publication of the European Spine Society, the European Spinal
Deformity Society, and the European Section of the Cervical Spine Research Society 22:2787–2799. https://doi.org/10.1007/ s00586-013-2850-1
63. Ghassibi M, Yen TC, Harris S, et al. Responsiveness of routine diagnostic tests for vertebral osteomyelitis may be influenced by the infecting organism. Spine J 2021;21(9):1479–88.
64. Siemionow K, Steinmetz M, Bell G, Ilaslan H, McLain RF. Identifying serious causes of back pain: cancer, infection, fracture. Cleve Clin J Med 2008; 75:557–66.
65. Maus, U.; Andereya, S.; Gravius, S.; Ohnsorge, J. a. K.; Milt- ner, O.; Niedhart, C. [Procalcitonin (PCT) as diagnostic tool for the monitoring of spondylodiscitis]. Z Orthop Unfall 2009, 147,
59–64, https://doi.org/10.1055/s-2008-1038974
66. Aljabi Y, Manca A, Ryan J, Elshawarby A (2019) Value of Pro- calcitonin as a Marker of Surgical Site Infection Following Spi- nal Surgery. Surgeon 17:97–101. https://doi.org/10.1016/j.surge.
2018.05.006
67. Kihira, S., Koo, C., Mahmoudi, K., Leong, T., Mei, X., Rigney, B., Aggarwal, A., and Doshi, A. H.: Combina- tion of Imaging Features and Clinical Biomarkers Pre- dicts Positive Pathology and
Microbiology Findings Sugges- tive of Spondylodiscitis in Patients Undergoing Image-Guided Percutaneous Biopsy, Am. J. Neuroradiol., 41, 1316–1322, https://doi.org/10.3174/ajnr.A6623,
2020
68. Darouiche RO. Spinal epidural abscess. N Engl J Med 2006;355(19):2012–20.
69. Del Pace S, Scheggi V, Virgili G, et al. Endocarditis with spondylodiscitis: clinical characteristics and prognosis. BMC Cardiovasc Disord 2021;21(1):186.
70. Di Bonaventura G., Angeletti S., Ianni A., Petitti T., Gherardi G. Microbiological Laboratory Diagnosis of Human Brucellosis: An Overview. Pathogens. 2021;10:1623. doi: 10.3390/pat-
hogens10121623. [DOI] [PMC free article] [PubMed] [Google Scholar] 71. Diaz R., Casanova A., Ariza J., Moriyon I. The Rose Bengal Test in human brucellosis: A neglected test for the diagnosis of a neglected disease. PLoS Negl. Trop. Dis. 2011;5:e950. doi: 10.1371/
journal.pntd.0000950. [DOI] [PMC free article] [PubMed] [Google Scholar] 72. Pappas G., Akritidis N., Bosilkovski M., Tsianos E. Brucellosis. N. Engl. J. Med. 2005;352:2325–2336. doi: 10.1056/NEJMra050570. [DOI] [PubMed] [Google Scholar] 73. Petri F, Mahmoud OK, Ranganath N, et al. Plasma microbial cell-free DNA Next- generation sequencing can be a useful diagnostic tool in patients with osteoar- ticular infections. Open
Forum Infect Dis 2024;11(7):ofae328.
74. Both A, Christner M, Berinson B, et al. The added value of a commercial 16S/18S-PCR assay (UMD-SelectNA, Molzym) for microbiological diagnosis of spondylodiscitis: an observational
study. Diagn Microbiol Infect Dis 2023; 106:115926.
75. Ma C, Wu H, Chen G, et al. The potential of metagenomic next-generation sequencing in diagnosis of spinal infection: a retrospective study. Eur Spine J 2022; 31:442.
76. Maamari J, Tande AJ, Diehn F, Tai DBG, Berbari EF (2022) Diagnosis of Vertebral Osteomyelitis. J Bone Joint Infect 7:23– 32. https://doi.org/10.5194/jbji-7-23-2022
77. Mavrogenis AF, Megaloikonomos PD, Igoumenou VG, Panago- poulos GN, Giannitsioti E, Papadopoulos A, Papagelopoulos PJ (2017) Spondylodiscitis Revisited EFORT Open Rev 2:447–
461. https://doi.org/10.1302/2058-5241.2.160062
78. An HS, Seldomridge JA. Spinal infections: diagnostic tests and imaging studies. Clin Orthop Relat Res 2006; 444:27
79. Diehn, F. E.: Imaging of Spine Infection, Radiol. Clin. N. Am., 50, 777–798, https://doi.org/10.1016/j.rcl.2012.04.001, 2012.
80. Dagirmanjian A, Schils J, McHenry M, Modic MT. MR imaging of vertebral osteomyelitis revisited. AJR Am J Roentgenol 1996; 167:1539
81. Ledermann HP, Schweitzer ME, Morrison WB, Carrino JA. MR imaging findings in spinal infections: rules or myths? Radiology 2003; 228:506
82. Carragee EJ. The clinical use of magnetic resonance imaging in pyogenic vertebral osteomyelitis. Spine (Phila Pa 1976) 1997; 22:780
83. Kamiya, N., Hatakeyama, S., Kanda, N., Yonaha, S., Akine, D., Ya- mamoto, Y., and Matsumura, M.: Significance of repeat magnetic resonance imaging in diagnosing vertebral osteomyelitis,
J. Gen.Fam. Med., 20, 68–71, https://doi.org/10.1002/jgf2.226, 2019.
84. Kowalski, T. J., Layton, K. F., Berbari, E. F., Steckelberg, J. M., Huddleston, P. M., Wald, J. T., and Osmon, D. R.: Follow-Up MR Imaging in Patients with Pyogenic Spine Infections: Lack of
Correlation with Clinical Features, Am. J. Neuroradiol., 28, 693–699, 2007.
85. Hong, S. H., Choi, J.-Y., Lee, J. W., Kim, N. R., Choi, J.-A., and Kang, H. S.: MR Imaging Assessment of the Spine: Infection or an Imitation?, RadioGraphics, 29, 599–612, https://doi.
org/10.1148/rg.292085137, 2009.
86. Herren C, Jung N, Pishnamaz M, Breuninger M, Siewe J, Sobottke R (2017) Spondylodiscitis: Diagnosis and Treatment Options. Dtsch Arztebl Int 114:875–882. https://doi.org/10.3238/
arztebl.2017.0875
87. Nickerson EK, Sinha R (2016) Vertebral Osteomyelitis in Adults: An Update. Br Med Bull 117:121–138. https://doi.org/10.1093/ bmb/ldw003
88. Palestro CJ (2016) Radionuclide Imaging of Musculoskeletal Infection: A Review. J Nucl Med 57:1406–1412. https://doi.org/ 10.2967/jnumed.115.157297
89. Raghavan M, Lazzeri E, Palestro CJ (2018) Imaging of Spon- dylodiscitis. Semin Nucl Med 48:131–147. https://doi.org/10. 1053/j.semnuclmed.2017.11.001
90. Hungenbach S, Delank K-S, Dietlein M, Eysel P, Drzezga A, Schmidt MC (2013) 18F-Fluorodeoxyglucose Uptake Pattern in Patients with Suspected Spondylodiscitis. Nucl Med Com- mun
34:1068–1074. https://doi.org/10.1097/MNM.0b013e3283 65abec
91. Kouijzer, I. J. E., Scheper, H., de Rooy, J. W. J., Bloem, J. L., Janssen, M. J. R., van den Hoven, L., Hosman, A. J. F., Visser, L. G., Oyen, W. J. G., Bleeker-Rovers, C. P., and de Geus-Oei, L.- F.: The
diagnostic value of 18F–FDG-PET/CT and MRI in sus- pected vertebral osteomyelitis – a prospective study, Eur. J. Nucl. Med. Mol. I., 45, 798–805, https://doi.org/10.1007/s00259-017- 3912-
0, 2018.
92. Paez, D.; Giammarile, F.; Brink, A.; García-Pérez, O.; Estrada- Lobato, E. The Role of 18-Fluorodeoxyglucose Positron Emis- sion Tomography/Computed Tomography (18F-FDG PET/CT)
in the Diagnosis and Evaluation of Spondylodiscitis. Seminars in Nuclear Medicine 2024, S0001299824000321, https://doi.org/ 10.1053/j.semnuclmed.2024.04.001.
93. Chong BSW, Brereton CJ, Gordon A, Davis JS. Epidemiology, Microbiological Diagnosis, and Clinical Outcomes in Pyogenic Vertebral Osteomyelitis: A 10-year Retrospective Cohort Study.
Open Forum Infect Dis 2018; 5:ofy037.
94. Weihe R, Taghlabi K, Lowrance M, et al. Culture Yield in the Diagnosis of Native Vertebral Osteomyelitis: A Single Tertiary Center Retrospective Case Series With Literature Review. Open
Forum Infect Dis 2022; 9:ofac026.
95. Chang CY, Simeone FJ, Nelson SB, et al. Is Biopsying the Paravertebral Soft Tissue as Effective as Biopsying the Disk or Vertebral Endplate? 10-Year Retrospective Review of CT-Guided Biopsy
of Diskitis-Osteomyelitis. AJR Am J Roentgenol 2015; 205:123.
96. Gras G, Buzele R, Parienti JJ, et al. Microbiological diagnosis of vertebral osteomyelitis: relevance of second percutaneous biopsy following initial negative biopsy and limited yield of post-bi-
opsy blood cultures. Eur J Clin Microbiol Infect Dis 2014; 33:371.
97. Czuczman GJ, Marrero DE, Huang AJ, et al. Diagnostic yield of repeat CT-guided biopsy for suspected infectious spondylodiscitis. Skeletal Radiol 2018; 47:1403
98. Trampuz A, Piper KE, Jacobson MJ, et al. Sonication of removed hip and knee prostheses for diagnosis of infection. N Engl J Med 2007; 357:654–63.
99. Marschall J, Bhavan KP, Olsen MA, Fraser VJ, Wright NM, War- ren DK (2011) The Impact of Prebiopsy Antibiotics on Pathogen Recovery in Hematogenous Vertebral Osteomyelitis. Clin
Infect Dis 52:867–872. https://doi.org/10.1093/cid/cir062
100. Saravolatz LD, Labalo V, Fishbain J, Szpunar S, Johnson LB (2018) Lack of Effect of Antibiotics on Biopsy Culture Results in Vertebral Osteomyelitis. Diagn Microbiol Infect Dis 91:273–274.
https://doi.org/10.1016/j.diagmicrobio.2018.02.017
101. Carroll R. Vertebral Osteomyelitis and Epidural Abscess. Med Clin North Am. 2025 May;109(3):601-614. doi: 10.1016/j.mcna.2024.12.007. Epub 2025 Jan 30. PMID: 40185549.
102. Modic MT, Feiglin DH, Piraino DW, Boumphrey F, Weinstein MA, Duchesneau PM, Rehm S (1985) Vertebral Osteomyelitis: Assessment Using MR. Radiology 157:157–166. https://doi.org/
10.1148/radiology.157.1.3875878
103. Michel-Batôt C, Dintinger H, Blum A, et al. A particular form of septic arthritis: septic arthritis of facet joint. Joint Bone Spine 2008; 75:78.
104. Widmer AF, Frei R, Rajacic Z, Zimmerli W. Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections. J Infect Dis 1990; 162:96.
105. Zimmerli W,Sendi P. Role of Rifampin against Staphylococcal Biofilm Infections In Vitro, in Animal Models, and in Orthopedic-Device-Related Infections. Antimicrob Agents Chemother
2019; 63.
106. Lacasse M, Derolez S, Bonnet E, et al. 2022 SPILF – Clinical Practice guidelines for the diagnosis and treatment of disco-vertebral infection in adults. Infect Dis Now 2023; 53:104647.
107. Li HK, Rombach I, Zambellas R, et al. Oral versus Intravenous Antibiotics for Bone and Joint Infection. N Engl J Med 2019; 380:425.
108. Babouee Flury B, Elzi L, Kolbe M, et al. Is switching to an oral antibiotic regimen safe after 2 weeks of intravenous treatment for primary bacterial vertebral osteomyelitis? BMC Infect Dis
2014; 14:226.
109. Ariza J., Gudiol F., Pallares R., Viladrich P.F., Rufi G., Corredoira J., Miravitlles M.R. Treatment of human brucellosis with doxycycline plus rifampin or doxycycline plus streptomycin. A
randomized, double-blind study. Ann. Intern. Med. 1992;117:25–30. doi: 10.7326/0003-4819-117-1-25. [DOI] [PubMed] [Google Scholar] 110. Giannitsioti E., Papadopoulos A., Nikou P., Athanasia S., Kelekis A., Economopoulos N., Drakou A., Papagelopoulos P., Papakonstantinou O., Sakka V., et al. Long-term triple-antibiotic
treatment against brucellar vertebral osteomyelitis. Int. J. Antimicrob. Agents. 2012;40:91–93. doi: 10.1016/j.ijantimicag.2012.03.018. [DOI] [PubMed] [Google Scholar] 111. Spernovasilis N, Karantanas A, Markaki I, Konsoula A, Ntontis Z, Koutserimpas C, Alpantaki K (2024) Brucella Spondylitis: Current Knowledge and Recent Advances. J Clin Med 13:595.
https://doi.org/10.3390/jcm13020595
112. Bosilkovski M., Keramat F., Arapovic J. The current therapeutical strategies in human brucellosis. Infection. 2021;49:823–832. doi: 10.1007/s15010-021-01586-w. [DOI] [PubMed] [Google
Scholar] 113. Bayindir Y., Sonmez E., Aladag A., Buyukberber N. Comparison of five antimicrobial regimens for the treatment of brucellar spondylitis: A prospective, randomized study. J. Chemother.
2003;15:466–471. doi: 10.1179/joc.2003.15.5.466. [DOI] [PubMed] [Google Scholar] 114. Smailnejad Gangi S.M., Hasanjani Roushan M.R., Janmohammadi N., Mehraeen R., Soleimani Amiri M.J., Khalilian E. Outcomes of treatment in 50 cases with spinal brucellosis in Babol,
Northern Iran. J. Infect. Dev. Ctries. 2012;6:654–659. doi: 10.3855/jidc.2175. [DOI] [PubMed] [Google Scholar] 115. 104.Koubaa M., Maaloul I., Marrakchi C., Lahiani D., Hammami B., Mnif Z., Ben Mahfoudh K., Hammami A., Ben Jemaa M. Spinal brucellosis in South of Tunisia: Review of 32 cases. Spine
J. 2014;14:1538–1544. doi: 10.1016/j.spinee.2013.09.027. [DOI] [PubMed] [Google Scholar] 116. Ioannou S, Karadima D, Pneumaticos S, et al. Efficacy of prolonged antimicrobial chemotherapy for brucellar spondylodiscitis. Clin Microbiol Infect 2011; 17:756.
117. Gulsun S., Aslan S., Satici O., Gul T. Brucellosis in pregnancy. Trop. Doct. 2011;41:82–84. doi: 10.1258/td.2011.100386. [DOI] [PubMed] [Google Scholar] 118. .Cebesoy F.B., Balat O., Mete A. An extraordinary cause of vertebral fracture in pregnant woman: Brucellosis. Arch. Gynecol. Obs. 2009;280:301–303. doi: 10.1007/s00404-008-0887-x. [DOI] [PubMed] [Google Scholar] –
119. Jain AK, Rajasekaran S, Jaggi KR, Myneedu VP (2020) Tuber- culosis of the Spine. J Bone Joint Surg 102:617–628. https:// doi.org/10.2106/JBJS.19.00001
120. Chew FS, Kline MJ. Diagnostic yield of CT-guided percutaneous aspiration procedures in suspected spontaneous infectious diskitis. Radiology 2001; 218:211–4.
121. Kowalski TJ, Berbari EF, Huddleston PM, Steckelberg JM, Osmon DR. Do follow-up imaging examinations provide useful prognostic infor- mation in patients with spine infection? Clin Infect
Dis 2006; 43:172–9.
122. Wang Q, Babyn P, Branson H, Tran D, Davila J, Mueller EL. Utility of MRI in the follow-up of pyogenic spinal infection in children. Pediatr Radiol 2010; 40:118–30.
123. Abe E, Yan K, Okada K. Pyogenic vertebral osteomyelitis presenting as single spinal compression fracture: a case report and review of the literature. Spinal Cord 2000; 38:639.
124. Markus HS. Haematogenous osteomyelitis in the adult: a clinical and epidemiological study. Q J Med 1989; 71:521.
125. Jevtic, V. Magnetic resonance imaging appearances of different discovertebral lesions. Eur. Radiol. 2001, 11, 1123–1135.
126. Bron, J.L.; de Vries, M.K.; Snieders, M.N.; van der Horst-Bruinsma, I.E.; van Royen, B.J. Discovertebral (Andersson) lesions of the spine in ankylosing spondylitis revisited. Clin. Rheumatol.
2009, 28, 883–892.
127. Wáng, Y.X.J.; Che-Nordin, N. Some radiographically ‘occult’ osteoporotic vertebral fractures can be evidential if we look carefully. Quant. Imaging Med. Surg. 2019, 9, 1992–1995